Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

181.40B

Market cap181.40B

Price-Earnings ratio

23.37

Price-Earnings ratio23.37

Dividend yield

2.87%

Dividend yield2.87%

Average volume

2.42M

Average volume2.42M

High today

$341.39

High today$341.39

Low today

$335.99

Low today$335.99

Open price

$338.23

Open price$338.23

Volume

1.93M

Volume1.93M

52 Week high

$391.29

52 Week high$391.29

52 Week low

$267.83

52 Week low$267.83

Stock Snapshot

The current Amgen(AMGN) stock price is $340.09, with a market capitalization of 181.4B. The stock trades at a price-to-earnings (P/E) ratio of 23.37 and offers a dividend yield of 2.9%.

On 2026-05-28, Amgen(AMGN) stock traded between a low of $335.99 and a high of $341.39. Shares are currently priced at $340.09, which is +1.2% above the low and -0.4% below the high.

The Amgen(AMGN)'s current trading volume is 1.93M, compared to an average daily volume of 2.42M.

During the past year, Amgen(AMGN) stock moved between $267.83 at its lowest and $391.29 at its peak.

AMGN News

Nasdaq 19h

AI Bots Crashed $10K in 2 Weeks While Our "Beat-the-Bot" Divvie Sails Higher

Think it's a good idea to ask ChatGPT to run your retirement portfolio? (I know that you don't, my careful contrarian. But we both have friends that are more t...

Simply Wall St 2d

Assessing Amgen Valuation After Japan Safety Concerns Over Rare Disease Drug - simplywall.st

...

Simply Wall St 5d

Does Amgen’s CFO Transition and Board Structure Shape a New Governance Story for AMGN?

Amgen has confirmed that executive vice president and chief financial officer Peter Griffith will retire, with former Amgen finance leader Thomas Dittrich rejoi...

Analyst ratings

49%

of 35 ratings

Buy

40%

Hold

48.6%

Sell

11.4%

More AMGN News

TipRanks 6d

Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Sam...

Simply Wall St 7d

Amgen CFO Change Puts Focus On Debt, Growth And Capital Discipline

Amgen announced that long-serving CFO Peter Griffith will retire from his role. Thomas Dittrich has been appointed as incoming CFO, with the transition marking...

The Wall Street Journal 7d

Amgen Drug Gets New Warnings in Japan After Patient Deaths

Amgen said U.S. guidance for Tavneos, also known as avacopan, has included information on the risk of serious liver injury since 2021. Smith Collection / Gado /...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.